Table 3.
CMR metric | AF | Stroke | IHD | MI | All-cause mortality | CVD mortality |
---|---|---|---|---|---|---|
LAVi (mL/m2) | 1.47* | 1.13 | 1.10 | 1.06 | 1.11 | 1.34* |
(1.28–1.70) | (0.98–1.31) | (1.01–1.19) | (0.93–1.21) | (1.00–1.23) | (1.05–1.71) | |
8.46 × 10−8 | 0.0807 | 0.0302 | 0.4002 | 0.0407 | 0.0185 | |
LAEF (%) | 0.64* | 0.83* | 0.88* | 0.87* | 0.96 | 0.85 |
(0.56–0.73) | (0.73–0.95) | (0.81–0.95) | (0.76–0.99) | (0.87–1.06) | (0.69–1.04) | |
2.50 × 10−11 | 0.0060 | 9.95 × 10−4 | 0.0294 | 0.4029 | 0.1119 | |
LVM : LVEDV | 1.06 | 1.22* | 1.27* | 1.14 | 1.09 | 1.05 |
(0.92–1.23) | (1.06–1.40) | (1.17–1.37) | (0.99–1.30) | (0.98–1.22) | (0.82–1.35) | |
0.4036 | 0.0065 | 1.27x10−8 | 0.0732 | 0.0959 | 0.7039 | |
LVGFI (%) | 0.92 | 0.89 | 0.88* | 0.95 | 0.85* | 0.61* |
(0.79–1.06) | (0.76–1.03) | (0.80–0.96) | (0.82–1.11) | (0.76–0.95) | (0.48–0.78) | |
0.2521 | 0.1266 | 0.0063 | 0.5372 | 0.0050 | 5.95 × 10−5 | |
GLS (%) | 0.97 | 1.10 | 1.08 | 1.05 | 1.14* | 1.10 |
(0.85–1.12) | (0.95–1.27) | (0.99–1.17) | (0.91–1.20) | (1.02–1.27) | (0.87–1.38) | |
0.7171 | 0.1880 | 0.0888 | 0.5254 | 0.0170 | 0.4314 |
Results are hazard ratios, 95% confidence intervals, and P-values. Covariates are LAV, LAEF, LVM/LVEDV, GLS, GLFI, age, sex, ethnicity, deprivation, education, body mass index, hypertension, high cholesterol, diabetes, physical activity, and smoking. The CMR variables are principal component analysis rotated variables.
AF, atrial fibrillation; CMR, cardiovascular magnetic resonance; CVD, cardiovascular disease; LVGFI, left ventricular global function index; GLS, global longitudinal strain; i, indicates indexation to body surface area; IHD, ischaemic heart disease; LAEF, left atrial ejection fraction; LAV, maximum left atrial volume; LVEDV, left ventricular end-diastolic volume; LVM, left ventricular mass; MI, myocardial infarction.
Statistically significant P-values with a false discovery rate of 0.05, giving an approximate threshold of 0.028.